These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2016749)

  • 1. Crystal structure of cleaved human alpha 1-antichymotrypsin at 2.7 A resolution and its comparison with other serpins.
    Baumann U; Huber R; Bode W; Grosse D; Lesjak M; Laurell CB
    J Mol Biol; 1991 Apr; 218(3):595-606. PubMed ID: 2016749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary structure changes stabilize the reactive-centre cleaved form of SERPINs. A study by 1H nuclear magnetic resonance and Fourier transform infrared spectroscopy.
    Perkins SJ; Smith KF; Nealis AS; Haris PI; Chapman D; Bauer CJ; Harrison RA
    J Mol Biol; 1992 Dec; 228(4):1235-54. PubMed ID: 1335516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of uncleaved ovalbumin at 1.95 A resolution.
    Stein PE; Leslie AG; Finch JT; Carrell RW
    J Mol Biol; 1991 Oct; 221(3):941-59. PubMed ID: 1942038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop.
    Wei A; Rubin H; Cooperman BS; Christianson DW
    Nat Struct Biol; 1994 Apr; 1(4):251-8. PubMed ID: 7656054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmin, angiotensinogen, and ovalbumin.
    Mast AE; Enghild JJ; Pizzo SV; Salvesen G
    Biochemistry; 1991 Feb; 30(6):1723-30. PubMed ID: 1704258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of cleaved equine leucocyte elastase inhibitor determined at 1.95 A resolution.
    Baumann U; Bode W; Huber R; Travis J; Potempa J
    J Mol Biol; 1992 Aug; 226(4):1207-18. PubMed ID: 1518052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural transition of alpha 1-antitrypsin by a peptide sequentially similar to beta-strand s4A.
    Schulze AJ; Baumann U; Knof S; Jaeger E; Huber R; Laurell CB
    Eur J Biochem; 1990 Nov; 194(1):51-6. PubMed ID: 2253623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of plakalbumin, a proteolytically nicked form of ovalbumin. Its relationship to the structure of cleaved alpha-1-proteinase inhibitor.
    Wright HT; Qian HX; Huber R
    J Mol Biol; 1990 Jun; 213(3):513-28. PubMed ID: 2352279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model of the reactive form of plasminogen activator inhibitor-1.
    Aertgeerts K; De Bondt HL; De Ranter C; Declerck PJ
    J Struct Biol; 1994; 113(3):239-45. PubMed ID: 7734247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the uncleaved serpin antichymotrypsin and its chymotrypsin complex.
    Katz DS; Christianson DW
    Protein Eng; 1993 Sep; 6(7):701-9. PubMed ID: 8248093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of ovalbumin as a model for the reactive centre of serpins.
    Stein PE; Leslie AG; Finch JT; Turnell WG; McLaughlin PJ; Carrell RW
    Nature; 1990 Sep; 347(6288):99-102. PubMed ID: 2395463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 1H NMR probe for mobility in the reactive center loops of serpins: spin-echo studies of native and modified forms of ovalbumin and alpha 1-proteinase inhibitor.
    Hood DB; Gettins P
    Biochemistry; 1991 Sep; 30(37):9054-60. PubMed ID: 1892818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the acute-phase protein alpha 1-antichymotrypsin in brain dysfunction and injury.
    Abraham CR
    Res Immunol; 1992; 143(6):631-6. PubMed ID: 1455055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-competition for binding of alpha 1-antitrypsin (alpha 1 AT)-elastase complexes to the serpin-enzyme complex receptor by other serpin-enzyme complexes and by proteolytically modified alpha 1 AT.
    Joslin G; Wittwer A; Adams S; Tollefsen DM; August A; Perlmutter DH
    J Biol Chem; 1993 Jan; 268(3):1886-93. PubMed ID: 8380581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolutionary relationships among the serpins.
    Marshall CJ
    Philos Trans R Soc Lond B Biol Sci; 1993 Oct; 342(1300):101-19. PubMed ID: 7904353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for serpin inhibitor activity.
    Wright HT; Scarsdale JN
    Proteins; 1995 Jul; 22(3):210-25. PubMed ID: 7479695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 2.6 A structure of a serpin polymer and implications for conformational disease.
    Huntington JA; Pannu NS; Hazes B; Read RJ; Lomas DA; Carrell RW
    J Mol Biol; 1999 Oct; 293(3):449-55. PubMed ID: 10543942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin III: structural and functional aspects.
    Mourey L; Samama JP; Delarue M; Choay J; Lormeau JC; Petitou M; Moras D
    Biochimie; 1990 Aug; 72(8):599-608. PubMed ID: 2126464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of latent alpha 1-antitrypsin.
    Lomas DA; Elliott PR; Chang WS; Wardell MR; Carrell RW
    J Biol Chem; 1995 Mar; 270(10):5282-8. PubMed ID: 7890640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The serpins alpha-1-antitrypsin and alpha-1-antichymotrypsin specifically interact with immunophilins.
    Feldkämper I; Verspohl EJ; Neye H
    Pharmazie; 2003 Nov; 58(11):811-6. PubMed ID: 14664338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.